UNSPSC 51401532: Iclazepam

This classification denotes a benzodiazepine with the molecular formula C21H21ClN2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier FL061Q6NMC, chemically known as 7-chloro-1-(2-(cyclopropylmethoxy)ethyl)-1,3-dihydro-5-phenyl-2h-1,4-benzodiazepin-2-one but generally known as iclazepam, which bears US NIH Compound Identifier 68777. European Medicines Agency schedules Iclazepam in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08105MIG.

UNSPSC 51401532 Iclazepam is a Commodity code that nominally covers benzodiazepine pharmaceuticals, but the recent state and local opportunity record shows procurement activity that does not align with this scope—the single tracked opportunity involves naloxone and drug deactivation systems rather than iclazepam specifically. State and local buyers using this code appear limited in number based on available records; the opportunity reflects activity by county health and emergency-response functions rather than a broader mix of issuing bodies across multiple jurisdictions.

Seminole County, Florida posted an IFB (Solicitation Number IFB60459723LAS) on June 30, 2026, to procure 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive bidding, with quarterly deliveries to the Seminole County Community Health Building at 520 W. Lake Mary Blvd, Sanford, Florida. The contract terms include a two-year initial period with a one-year renewal option, fixed-fee pricing, E-Verify compliance, workers' compensation and commercial general liability insurance, and a three-month probationary termination clause. Vendors must include all shipping and delivery costs in their proposals and submit bids electronically through the county's e-Procurement Portal. The procurement does not specify set-aside designations and may be funded through FEMA, which introduces Clean Air Act and Federal Water Pollution Control Act compliance requirements. The mismatch between the code's nominal pharmaceutical scope and the actual solicitation suggests this code may not see sustained state and local activity aligned with its original taxonomy definition.